BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1464469)

  • 21. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction.
    Sharma BS; Mhaskar S; Balazs L; Jin A; Smee DF
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanism of action of a synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738), in natural killer cell activation in animals.
    Ruszala-Mallon V; Silva J; Lumanglas AL; Durr FE; Wang BS
    Int J Immunopharmacol; 1991; 13(7):913-21. PubMed ID: 1722194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole.
    Keenan JA; Williams-Boyce PK; Massey PJ; Chen TT; Caudle MR; Bukovsky A
    Fertil Steril; 1999 Jul; 72(1):135-41. PubMed ID: 10428162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB
    Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
    Biron CA; Young HA; Kasaian MT
    J Exp Med; 1990 Jan; 171(1):173-88. PubMed ID: 1688606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of manganese, calcium, magnesium, and zinc on nickel-induced suppression of murine natural killer cell activity.
    Smialowicz RJ; Rogers RR; Riddle MM; Luebke RW; Fogelson LD; Rowe DG
    J Toxicol Environ Health; 1987; 20(1-2):67-80. PubMed ID: 3806706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo augmentation of natural killer cell activity by Candida albicans.
    Wojdani A; Ghoneum M
    Int J Immunopharmacol; 1987; 9(7):827-32. PubMed ID: 3323078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic intracerebroventricular administration of beta-endorphin augments natural killer cell cytotoxicity in rats.
    Jonsdottir IH; Johansson C; Asea A; Hellstrand K; Thorén P; Hoffmann P
    Regul Pept; 1996 Apr; 62(2-3):113-8. PubMed ID: 8795073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of murine NK cell activity generation by ST 789.
    Riccardi C; Migliorati G
    Thymus; 1992; 19 Suppl 1():S109-12. PubMed ID: 1585416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2.
    Cohen BL; Orn A; Gronvik KO; Gidlund M; Wigzell H; Murgita RA
    Scand J Immunol; 1986 Feb; 23(2):211-23. PubMed ID: 2419966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice.
    Smee DF; Alaghamandan HA; Gilbert J; Burger RA; Jin A; Sharma BS; Ramasamy K; Revankar GR; Cottam HB; Jolley WB
    Antimicrob Agents Chemother; 1991 Jan; 35(1):152-7. PubMed ID: 1707603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered production and renewal of natural killer cells in B-lymphocyte-deficient CBA/N mice.
    Miller SC; Christopher FL
    Nat Immun Cell Growth Regul; 1989; 8(5):245-54. PubMed ID: 2594018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of natural killer activity and IFN-γ production in an IL-12-dependent manner by a Brassica rapa L.
    Yamamoto K; Furuya K; Yamada K; Takahashi F; Hamajima C; Tanaka S
    Biosci Biotechnol Biochem; 2018 Apr; 82(4):654-668. PubMed ID: 29207919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of natural killer cell activity in healthy subjects by Immulina®, a Spirulina extract enriched for Braun-type lipoproteins.
    Nielsen CH; Balachandran P; Christensen O; Pugh ND; Tamta H; Sufka KJ; Wu X; Walsted A; Schjørring-Thyssen M; Enevold C; Pasco DS
    Planta Med; 2010 Nov; 76(16):1802-8. PubMed ID: 20560112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
    Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
    J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
    Lauria F; Raspadori D; Ventura MA; Rondelli D; Zinzani PL; Gherlinzoni F; Miggiano MC; Fiacchini M; Rosti G; Rizzi S; Tura S
    Bone Marrow Transplant; 1996 Jul; 18(1):79-85. PubMed ID: 8831999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and activity of dipeptides, linked to targeting ligands, as specific NK cell enhancers.
    Abbott SD; Gagnon L; Lagraoui M; Kadhim S; Attardo G; Zacharie B; Penney CL
    J Med Chem; 1998 May; 41(11):1909-26. PubMed ID: 9599240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.